NEW YORK UNIVERSITY A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut. The study, led by researchers at New York University College of Dentistry and Queen’s University in Ontario, was conducted in mice with colitis,...